Onyx Biotec Limited was established as Onyx Biotec Private Limited', pursuant to a Certificate of Incorporation dated May 13, 2005 as registered with the Registrar of Companies, Punjab, H.P. & Chandigarh. Further, Company converted into a Public Limited and the name was changed to Onyx Biotec Limited' and a fresh Certificate of Incorporation dated July 23, 2024 was as registered with the Registrar of Companies, Central Processing Centre.

Onyx started its operation in pharmaceutical industry with sterile water for injections with capacity of 2 lacs units per day in year 2010. Since then, Onyx is engaged in Manufacturing of Pharmaceutical Products such as sterile water ampoule, dry injection, dry syrup etc. to major corporations, which includes the top pharma companies.

Presently, the Company manufactures Sterile Water for Injections, and acts as a pharmaceutical contract manufacturer offering a comprehensive range of Dry Powder Injections and Dry Syrup for India and overseas. The core business is on providing end-to-end product development and manufacturing solutions to clients. The service include preparation and filing of regulatory dossiers in the Indian and global markets.

the Company has Unit I and Unit II manufacturing plants in Solan District of Himachal Pradesh. The facility Unit I is having production capacity of 6,38,889 units of Sterile Water for Injections per day and Unit II is having a capacity of 40,000 units of dry Powder injection per day and 26,667 units of dry syrup per day in a single shift.

the Company later on, enhanced the capacity expansion from 130 million unit per annum to 230 million units per annum capacity in 2017-18. Further, the Company commenced their Unit II commercial production in 2023.

Company is planning an IPO of 48,10,000 Fresh Issue Equity Shares.